From CBC News:
Four years after it was passed unanimously by Parliament, a bill drafted to allow low-cost Canadian-made AIDS drugs to be exported to developing countries may finally be on the verge of producing results.
Generic drug maker Apotex Inc. announced Wednesday that it has been awarded a contract by the government of Rwanda to sell its three-in-one AIDS pill Apo Triavir to the African country. Securing that contract was the final legal hurdle that Apotex had to manoeuvre in the onerous process of making Canada's Access to Medicines Regime work.
"We're almost there," Elie Betito, the company's director of public and government affairs, said in an interview.
"By October sometime we're hoping that the product will be on a plane on delivery to Rwanda."
He noted, though, that nothing will be final until that actually happens. The companies that hold the patents on the drugs in the Apotex combined medication can still withdraw permission for the sale to take place "even on the day we are shipping." ...more
Showing posts with label Access to Medicines Regime. Show all posts
Showing posts with label Access to Medicines Regime. Show all posts
Sunday, May 11, 2008
Tuesday, December 04, 2007
Life-saving meds wrapped in red tape
From the McGill (Que.) Daily:
Six months after Industry Canada finished its review of legislation that allows Canadian drug manufacturers to produce and export generic medicines, a report of the findings has yet to be completed.
The legislation, known as the Canada Access to Medicines Regime (CAMR), was passed in 2004 to facilitate access to affordable essential medicines in developing countries. But the legislation is widely recognized as flawed – so far, not a single pill has left the country. ...more
Six months after Industry Canada finished its review of legislation that allows Canadian drug manufacturers to produce and export generic medicines, a report of the findings has yet to be completed.
The legislation, known as the Canada Access to Medicines Regime (CAMR), was passed in 2004 to facilitate access to affordable essential medicines in developing countries. But the legislation is widely recognized as flawed – so far, not a single pill has left the country. ...more
Thursday, August 09, 2007
Canadian companies agree to share generic AIDS drugs with Rwanda
From the Globe and Mail:
AIDS drugs could be heading for Rwanda as soon as November under a Canadian program that allows generic-drug companies to send copies of brand-name medicines to poor countries.
GlaxoSmithKline Inc. said yesterday it had given consent to Apotex Inc. to manufacture an antiretroviral medication for the treatment of HIV/AIDS patients in Rwanda. Consent, through Canada's Access to Medicines Regime, was needed as GSK has patent rights for two of the three molecules in the medication.
"We have made a commitment, we have the drug and if we can get the green light, we will move quickly on it," said Elie Betito, director of public and government affairs for Apotex Inc. ...more
AIDS drugs could be heading for Rwanda as soon as November under a Canadian program that allows generic-drug companies to send copies of brand-name medicines to poor countries.
GlaxoSmithKline Inc. said yesterday it had given consent to Apotex Inc. to manufacture an antiretroviral medication for the treatment of HIV/AIDS patients in Rwanda. Consent, through Canada's Access to Medicines Regime, was needed as GSK has patent rights for two of the three molecules in the medication.
"We have made a commitment, we have the drug and if we can get the green light, we will move quickly on it," said Elie Betito, director of public and government affairs for Apotex Inc. ...more
Subscribe to:
Posts (Atom)
